Title: MMWR Vol. 58 / Early Release
| If you have trouble reading this e-mail, please click here.
|
|
|
Early Release
Volume 58, Early Release
December 4, 2009
|
|
|
|
|
Safety of Influenza A (H1N1) 2009 Monovalent Vaccines
United States, October 1--November 24, 2009
|
|
|
|
|
| Vaccine safety monitoring is an important component of all vaccination programs. To assess the safety of H1N1 vaccines in the United States, CDC reviewed results from the U.S. Vaccine Adverse Event Reporting System and Vaccine Safety Datalink as of November 24. VAERS data indicated 82 adverse event reports per 1 million H1N1 vaccine doses distributed, compared with 47 reports for
seasonal influenza vaccine. However, no substantial differences were noted in the serious adverse events reported for the two vaccine types, and no increase in any adverse events has been seen in VSD data.
|
 full text
|
|
|
|
Department of Health and Human Services
Centers for Disease Control and Prevention
|
|
|
Modify/Update Subscriber Preferences | Unsubscribe | Send Feedback | Learn more about CDC Email Updates
To receive the latest news for your region, please update your profile with your country, state and zip code.
Questions or problems? Please contact support@xxxxxxxxxxxxxxx.
Centers for Disease Control and Prevention (CDC) · 1600 Clifton Rd · Atlanta GA 30333 · 800-CDC-INFO (800-232-4636)
